Consolidated Statement Of Income

TORII PHARMACEUTICAL CO., LTD. - Filing #7340452

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Consolidated statement of income
Statement of income
Net sales
13,451,000,000 JPY
11,811,000,000 JPY
Operating expenses
Selling, general and administrative expenses
4,580,000,000 JPY
5,960,000,000 JPY
Other
2,504,000,000 JPY
2,265,000,000 JPY
Cost of sales
7,487,000,000 JPY
6,288,000,000 JPY
Operating expenses
Operating profit (loss)
1,383,000,000 JPY
-437,000,000 JPY
Gross profit (loss)
5,963,000,000 JPY
5,522,000,000 JPY
Ordinary profit (loss)
1,166,000,000 JPY
-404,000,000 JPY
Operating expenses
Research and development expenses
532,000,000 JPY
2,057,000,000 JPY
Net sales
Non-operating income
83,000,000 JPY
70,000,000 JPY
Dividend income
JPY
1,000,000 JPY
Interest income
75,000,000 JPY
62,000,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating income
Other
7,000,000 JPY
6,000,000 JPY
Extraordinary losses
6,000,000 JPY
1,000,000 JPY
Non-operating expenses
300,000,000 JPY
37,000,000 JPY
Interest expenses
0 JPY
0 JPY
Non-operating expenses
Other
9,000,000 JPY
0 JPY
Profit (loss) before income taxes
1,160,000,000 JPY
-405,000,000 JPY
Gross profit
Extraordinary losses
Loss on retirement of non-current assets
6,000,000 JPY
1,000,000 JPY
Income taxes
281,000,000 JPY
-116,000,000 JPY
Profit (loss)
878,000,000 JPY
-288,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.